Bristol Myers Squibb (BMY) Other Working Capital Changes (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Other Working Capital Changes data on file, last reported at $1.6 billion in Q1 2026.

• Quarterly Other Working Capital Changes rose 54.49% year-over-year to $1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.0 million (up 161.27% YoY) and the FY2025 annual result came in at -$471.0 million, up 24.52% from the prior year.
• Other Working Capital Changes climbed to $1.6 billion in Q1 2026 per BMY's latest filing, from -$1.1 billion in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $1.6 billion in Q1 2026 and bottomed at -$1.1 billion in Q4 2025.
• The 5-year median for Other Working Capital Changes is -$167.0 million (2024), against an average of $106.9 million.
• The widest annual swing landed in 2022, when Other Working Capital Changes surged 185.27%; it then sank 383.05% in 2024.
• Tracing BMY's Other Working Capital Changes over 5 years: stood at -$700.0 million in 2022, then surged by 59.57% to -$283.0 million in 2023, then sank by 156.18% to -$725.0 million in 2024, then tumbled by 47.31% to -$1.1 billion in 2025, then surged by 253.18% to $1.6 billion in 2026.
• Per Business Quant, the three latest BMY Other Working Capital Changes figures stand at $1.6 billion (Q1 2026), -$1.1 billion (Q4 2025), and -$240.0 million (Q3 2025).

Peer Comparison